Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Revenue

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹11,583 Cr₹12,305 Cr₹10,944 Cr₹10,641 Cr₹9,865 Cr

What is the latest Revenue of GLENMARK PHARMACEUTICALS ?

The latest Revenue ratio of GLENMARK PHARMACEUTICALS is ₹11,583 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹11,583 Cr
Mar2023₹12,305 Cr
Mar2022₹10,944 Cr
Mar2021₹10,641 Cr
Mar2020₹9,865 Cr

How is Revenue of GLENMARK PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹11,583 Cr
-5.86
Mar2023 ₹12,305 Cr
12.44
Mar2022 ₹10,944 Cr
2.85
Mar2021 ₹10,641 Cr
7.86
Mar2020 ₹9,865 Cr -

Compare Revenue of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,513.6 Cr -1.8% 23.9% 50.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹123,675.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 1.4% -3.3% -7.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.8%

23.9%

50.5%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses